Jun 2026 (Q2 FY26) — Jul 30, 2026
Exponent Q2 FY26 — Double-Digit Growth Driven by AI-Enabled Demand and Strategic Share Repurchases
Read the full callExponent earnings: last reported Thu, 30 Jul 2026, for the quarter ended Jun 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 172 | +20.9% YoY | Quarterly, as filed | Quarter to Jul 2026 | Revenue from operations as filed. |
| Operating margin | 16.3 | +4.2 pts YoY | Operating profit / revenue | Quarter to Jul 2026 | For the quarter; a change is in percentage points. |
| Net profit | 29.4 | +10.7% YoY | Quarterly, as filed | Quarter to Jul 2026 | Profit after tax as filed. |
Price
1Y: $67.5 on 17 Oct 2025 → $72.25. High $79.79 (6 Feb 2026), low $53.67 (14 May 2026).
Overview
Call summaries
Exponent Q2 FY26 — Double-Digit Growth Driven by AI-Enabled Demand and Strategic Share Repurchases
Read the full callEvery analysed call
Financials
Net profit, year on year: +11% (quarter to jul 2026 against jul 2025).
| Line item | Sep 2024 | Jan 2025 | Apr 2025 | Jul 2025 | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 136 | 137 | 146 | 142 | 147 | 147 | 166 | 172 |
| Operating profit | 26 | 27 | 44 | 17 | 29 | 29 | 41 | 28 |
| Operating margin | 19.0% | 19.9% | 30.5% | 12.1% | 19.7% | 19.8% | 24.9% | 16.3% |
| Other income | 10 | — | -7 | 20 | 10 | — | 1 | 13 |
| Profit before tax | 36 | 31 | 38 | 37 | 39 | 34 | 42 | 41 |
| Tax rate | 27.5% | 24.7% | 29.4% | 27.9% | 27.4% | 27.4% | 30.2% | 27.9% |
| Net profit | 26 | 24 | 27 | 27 | 28 | 25 | 30 | 29 |
| EPS ($ per share) | 0.51 | — | 0.52 | 0.52 | 0.55 | — | 0.59 | 0.60 |
| Line item | Dec 2018 | Jan 2020 | Jan 2021 | Dec 2021 | Dec 2022 | Dec 2023 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | 342 | 385 | 422 | 478 | 529 | 574 | 624 | 668 |
| Total liabilities | 155 | 213 | 219 | 267 | 266 | 291 | 356 | 387 |
| Fixed assets | 46 | 62 | 60 | 60 | 66 | 75 | 73 | 72 |
| Investments | 81 | 55 | 45 | — | — | — | — | — |
| Total assets | 469 | 563 | 580 | 684 | 587 | 647 | 777 | 778 |
| Line item | Dec 2018 | Jan 2020 | Jan 2021 | Dec 2021 | Dec 2022 | Dec 2023 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 91 | 108 | 103 | 125 | 94 | 127 | 145 | 132 |
| Cash from investing | -26 | 4 | 5 | 38 | -12 | -16 | -7 | -9 |
| Cash from financing | -62 | -63 | -88 | -63 | -216 | -86 | -65 | -160 |
| Net cash flow | 2 | 49 | 21 | 100 | -136 | 26 | 72 | -37 |
| Capital expenditure | -16 | -23 | -5 | -7 | -12 | -16 | -7 | -9 |
| Free cash flow | 75 | 85 | 98 | 118 | 82 | 111 | 138 | 122 |
65 filings between Nov 17, 2025 and Sep 18, 2026.
Purchases
$12.6K
1 purchase by 1 insider
Sales
$2.96M
22 sales by 6 insiders
73% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Also filed: 1 gift.
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Corrigan Catherine | — | $2.17M | Aug 17, 2026 |
| Pye John | — | $303.9K | Feb 10, 2026 |
| Rakow Joseph | — | $161.0K | May 13, 2026 |
| Sala Joseph | — | $117.1K | May 13, 2026 |
| James Bradley A | — | $114.9K | May 26, 2026 |
| Reiss Richard | — | $98.1K | May 19, 2026 |
| Souri Shukri Jeries | $12.6K | — | Sep 18, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 18, 2026 | Souri Shukri Jeries Group Vice President | Purchase | 184 | $12.6K |
| Aug 17, 2026 | Corrigan Catherine Chief Executive Officer | Option exercise 10b5-1 plan | 2,379 | $69.1K |
| Aug 17, 2026 | Corrigan Catherine Chief Executive Officer | Sale 10b5-1 plan | 1,707 | $113.1K |
| Jul 28, 2026 | Corrigan Catherine Chief Executive Officer | Option exercise | 12,665 | $474.3K |
| Jul 15, 2026 | Corrigan Catherine Chief Executive Officer | Option exercise 10b5-1 plan | 2,379 | $69.1K |
| Jul 15, 2026 | Corrigan Catherine Chief Executive Officer | Sale 10b5-1 plan | 1,737 | $109.0K |
| Jun 25, 2026 | Corrigan Catherine Chief Executive Officer | Option exercise | 7,872 | $200.0K |
| Jun 15, 2026 | Corrigan Catherine President & CEO | Option exercise 10b5-1 plan | 3,225 | $81.9K |
| Jun 15, 2026 | Corrigan Catherine President & CEO | Sale 10b5-1 plan | 2,326 | $132.9K |
| Jun 15, 2026 | Corrigan Catherine President & CEO | Sale 10b5-1 plan | 1,793 | $102.4K |
| Jun 15, 2026 | Corrigan Catherine President & CEO | Option exercise 10b5-1 plan | 2,380 | $69.1K |
| Jun 3, 2026 | Brown George H. Director | Option exercise | 2,009 | — |
| Jun 3, 2026 | Lindstrom Carol Director | Option exercise | 2,009 | — |
| Jun 3, 2026 | RICHARDSON KAREN A Director | Option exercise | 2,009 | — |
| Jun 3, 2026 | Zumwalt Debra Director | Option exercise | 2,009 | — |
| Jun 3, 2026 | JOHNSTON PAUL R Director | Option exercise | 2,009 | — |
| May 26, 2026 | James Bradley A Group Vice President | Sale | 2,000 | $114.9K |
| May 19, 2026 | Reiss Richard Group Vice President | Sale | 1,672 | $98.1K |
| May 15, 2026 | Corrigan Catherine President & CEO | Sale 10b5-1 plan | 1,827 | $98.8K |
| May 15, 2026 | Corrigan Catherine President & CEO | Option exercise 10b5-1 plan | 3,226 | $82.0K |
| May 15, 2026 | Corrigan Catherine President & CEO | Option exercise 10b5-1 plan | 2,380 | $69.1K |
| May 15, 2026 | Corrigan Catherine President & CEO | Sale 10b5-1 plan | 2,367 | $128.0K |
| May 13, 2026 | Sala Joseph Group Vice President | Sale | 2,066 | $117.1K |
| May 13, 2026 | Rakow Joseph Group Vice President | Sale | 2,945 | $161.0K |
| Apr 15, 2026 | Corrigan Catherine President & CEO | Option exercise 10b5-1 plan | 2,380 | $69.1K |
| Apr 15, 2026 | Corrigan Catherine President & CEO | Sale 10b5-1 plan | 2,212 | $149.7K |
| Apr 15, 2026 | Corrigan Catherine President & CEO | Option exercise 10b5-1 plan | 3,225 | $81.9K |
| Apr 15, 2026 | Corrigan Catherine President & CEO | Sale 10b5-1 plan | 1,697 | $114.9K |
| Mar 16, 2026 | Corrigan Catherine President & CEO | Sale 10b5-1 plan | 1,698 | $114.6K |
| Mar 16, 2026 | Corrigan Catherine President & CEO | Sale 10b5-1 plan | 2,214 | $149.4K |
| Mar 16, 2026 | Corrigan Catherine President & CEO | Option exercise 10b5-1 plan | 2,380 | $69.1K |
| Mar 16, 2026 | Corrigan Catherine President & CEO | Option exercise 10b5-1 plan | 3,226 | $82.0K |
| Mar 11, 2026 | Corrigan Catherine President & CEO | Option exercise | 12,716 | — |
| Mar 11, 2026 | Reiss Richard Group Vice President | Option exercise | 2,120 | — |
| Mar 11, 2026 | SCHLENKER RICHARD L JR EVP & Chief Financial Officer | Tax withheld | 3,694 | $258.7K |
| Mar 11, 2026 | SCHLENKER RICHARD L JR EVP & Chief Financial Officer | Option exercise | 7,630 | — |
| Mar 11, 2026 | Sala Joseph Group Vice President | Option exercise | 3,180 | — |
| Mar 11, 2026 | Reitman Maureen T. F. Group Vice President | Tax withheld | 1,756 | $123.0K |
| Mar 11, 2026 | Reitman Maureen T. F. Group Vice President | Option exercise | 5,510 | — |
| Mar 11, 2026 | Rakow Joseph Group Vice President | Tax withheld | 2,353 | $164.8K |
| Mar 11, 2026 | Rakow Joseph Group Vice President | Option exercise | 5,298 | — |
| Mar 11, 2026 | Sala Joseph Group Vice President | Tax withheld | 1,114 | $78.0K |
| Mar 11, 2026 | Pye John VP Global Offices & Innovation | Tax withheld | 2,384 | $167.0K |
| Mar 11, 2026 | Pye John VP Global Offices & Innovation | Option exercise | 5,934 | — |
| Mar 11, 2026 | James Bradley A Group Vice President | Tax withheld | 1,559 | $109.2K |
| Mar 11, 2026 | Reiss Richard Group Vice President | Tax withheld | 958 | $67.1K |
| Mar 11, 2026 | James Bradley A Group Vice President | Option exercise | 4,664 | — |
| Mar 11, 2026 | Corrigan Catherine President & CEO | Tax withheld | 6,156 | $431.1K |
| Feb 27, 2026 | Reitman Maureen T. F. Group Vice President | Gift | 140 | — |
| Feb 17, 2026 | Corrigan Catherine President & CEO | Sale 10b5-1 plan | 2,218 | $149.0K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow EXPONENT INC and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading